Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.96
+0.43 (7.69%)
At close: Dec 20, 2024, 1:15 PM
5.98
+0.02 (0.34%)
After-hours: Dec 20, 2024, 6:26 PM EST
Serina Therapeutics Revenue
Serina Therapeutics had revenue of $14.00K in the quarter ending September 30, 2024, a decrease of -51.72%. This brings the company's revenue in the last twelve months to $3.16M, up 2,454.55% year-over-year. In the year 2023, Serina Therapeutics had annual revenue of $3.15M with 433.14% growth.
Revenue (ttm)
$3.16M
Revenue Growth
+2,454.55%
P/S Ratio
10.90
Revenue / Employee
$287,045
Employees
11
Market Cap
56.35M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.15M | 2.56M | 433.14% |
Dec 31, 2022 | 591.50K | -2.87M | -82.93% |
Dec 31, 2021 | 3.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSER News
- 5 days ago - Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - GlobeNewsWire
- 10 days ago - Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewsWire
- 19 days ago - Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - GlobeNewsWire
- 3 months ago - Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 5 months ago - Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit - GlobeNewsWire